News

First MRI-compatible implantable defibrillator approved

Publish date: September 18, 2015

 

References

The Evera MRI Study was sponsored by Medtronic, which produces and will market the Evera ICD. Dr. Gold has been a consultant to and has received research and speaker funding from Medtronic as well as from Boston Scientific and St. Jude. Dr. Passman has received research support from Medtronic but not for work on ICDs.

mzoler@frontlinemedcom.com

On Twitter @mitchelzoler

Pages

Recommended Reading

Heart failure’s surprises keep coming
MDedge Cardiology
VIDEO: Adverse ventilation effect means rethinking Cheyne-Stokes respiration
MDedge Cardiology
ESC: CERTITUDE casts doubt on defibrillator benefit in CRT
MDedge Cardiology
Collaboration helped reduce heart failure readmissions
MDedge Cardiology
ESC: Most heart failure patients’ rehospitalizations are for other reasons
MDedge Cardiology
VIDEO: Patients use CardioMEMS feedback to improve self-management
MDedge Cardiology
ESC: Zero risk of death in pregnant women with severe aortic stenosis
MDedge Cardiology
ESC: Heart failure risk climbs early in childhood cancer survivors
MDedge Cardiology
ESC: Further data indicate no excess heart failure risk with lixisenatide or sitagliptin
MDedge Cardiology
ESC: Noncardiac surgery in HCM patients warrants special attention
MDedge Cardiology

Related Articles